Alpha DNA Investment Management’s Associated Banc-Corp ASB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-58,759
Closed -$1.06M 157
2023
Q1
$1.06M Buy
58,759
+11,232
+24% +$246K 0.31% 100
2022
Q4
$1.1M Buy
47,527
+18,470
+64% +$426K 0.39% 77
2022
Q3
$583K Buy
+29,057
New +$584K 0.48% 85

Other funds holding ASB

Alpha DNA Investment Management's ASB Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of Associated Banc-Corp (ASB) in Q2 2023, closing a stake of 58,759 shares — an estimated $1.06M sold.

Alpha DNA Investment Management first reported a position in ASB in Q3 2022 and held it in 3 quarters. The position peaked at $1.1M in Q4 2022. 264 funds tracked by Wall St. Rank hold ASB as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining Associated Banc-Corp position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 58,759 Associated Banc-Corp shares in Q2 2023, an estimated $1.06M.
  • Alpha DNA Investment Management first reported a position in Associated Banc-Corp in Q3 2022 and held it in 3 quarters.
  • Alpha DNA Investment Management's Associated Banc-Corp position peaked at $1.1M in Q4 2022.
  • 264 funds tracked by Wall St. Rank held Associated Banc-Corp as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.